Should we use bosentan to treat systemic sclerosis associated pulmonary hypertension in the presence of pulmonary fibrosis?

被引：0
|
作者：
Kabunga, P. [1 ]
Handler, C. E. [1 ]
Das, C. [1 ]
Kotecha, A. [1 ]
Denton, C. [1 ]
Reddecliffe, S. [1 ]
Black, C. [1 ]
Smith, C. [2 ]
Coghlan, J. G. [1 ]
机构：
[1] Royal Free Hosp, London NW3 2QG, England
[2] UCL, Sch Med, London W1N 8AA, England
来源：
EUROPEAN HEART JOURNAL | 2007年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：125 / 125
页数：1
相关论文
共 50 条
  • [31] Bosentan Ameliorated Exercise-Induced Pulmonary Arterial Hypertension Complicated with Systemic Sclerosis
    Yagi, Shusuke
    Akaike, Masashi
    Iwase, Takashi
    Kusunose, Kenya
    Niki, Toshiyuki
    Yamaguchi, Koji
    Koshiba, Kunihiko
    Yoshida, Sumiko
    Sumitomo-Ueda, Yuka
    Aihara, Ken-ichi
    Hirata, Yoichiro
    Dagvasumberel, Munkhbaatar
    Taketani, Yoshio
    Tomita, Noriko
    Yamada, Hirotsugu
    Soeki, Takeshi
    Wakatsuki, Tetsuzo
    Matsumoto, Toshio
    Sata, Masataka
    INTERNAL MEDICINE, 2010, 49 (21) : 2309 - 2312
  • [32] IS PULMONARY ARTERIAL HYPERTENSION, ASSOCIATED WITH SYSTEMIC SCLEROSIS REVERSIBLE?
    Volkov, A.
    Yudkina, N.
    Nikolaeva, E.
    Starovoytova, M.
    Alekseeva, O.
    Nikishina, I.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1603 - 1604
  • [33] Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
    Chaisson, Neal F.
    Hassoun, Paul M.
    CHEST, 2013, 144 (04) : 1346 - 1356
  • [34] Systemic Sclerosis-associated Pulmonary Arterial Hypertension
    Le Payec, Jerome
    Humbert, Marc
    Mouthon, Luc
    Hassoun, Paul M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181 (12) : 1285 - 1293
  • [35] Cardiopulmonary phenotype in systemic sclerosis associated pulmonary hypertension
    Santana, Luis Javier Cajas
    Giraldo, Alejandro Correa
    Torres, Maria Carolina
    REUMATOLOGIA CLINICA, 2024, 20 (05): : 243 - 248
  • [36] Successful Treatment with Bosentan for Pulmonary Hypertension and Reduced Peripheral Circulation in Juvenile Systemic Sclerosis
    Shimizu, Masaki
    Hashida, Yoko
    Ueno, Kazuyuki
    Yokoyama, Tadafumi
    Nakayama, Yuko
    Saito, Takekatsu
    Ohta, Kunio
    Takehara, Kazuhiko
    Yachie, Akihiro
    PEDIATRIC CARDIOLOGY, 2011, 32 (07) : 1040 - 1042
  • [37] Impact of bosentan therapy on stress-induced pulmonary hypertension in patients with systemic sclerosis
    Volkov, A. V.
    Kurmukov, I. A
    Yudkina, N. N.
    Glukhova, S. I.
    Nikolaeva, E. V.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (01) : 49 - 56
  • [38] CLINICALSUBTYPE OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH SYSTEMIC SCLEROSIS
    Yudkina, Natalia
    Volkov, Alexander
    Nikolaeva, Ekaterina
    Kurmukov, Ildar
    Nasonov, Evgeny
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1569 - 1570
  • [39] Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis
    Hofstee, H. M. A.
    Noordegraaf, A. Vonk
    Voskuyl, A. E.
    Dijkmans, B. A. C.
    Postmus, P. E.
    Smulders, Y. M.
    Serne, E. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (02) : 191 - 195
  • [40] Bosentan for severe pulmonary arterial hypertension related to systemic sclerosis with interstitial lung disease
    Ahmadi-Simab, K.
    Helimich, B.
    Gross, W. L.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 : 44 - 48
12345